Gastroparesis is a disease in which the stomach cannot empty itself of food in a normal fashion. Symptoms include heartburn, nausea, vomiting, and feeling full quickly when eating. Treatments include medications and possibly surgery.
This report contains market size and forecasts of Gastroparesis Treatment in Global, including the following market information:
Global Gastroparesis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gastroparesis Treatment market was valued at 3923.4 million in 2021 and is projected to reach US$ 4539.4 million by 2028, at a CAGR of 2.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drug Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gastroparesis Treatment include Medtronic, Abbott, Bausch Health, Boston Scientific, C.R. Bard, Johnson & Johnson, Cardinal Health, Evoke Pharma and Rhythm Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastroparesis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastroparesis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gastroparesis Treatment Market Segment Percentages, by Type, 2021 (%)
Drug Treatment
Surgical Treatment
Global Gastroparesis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gastroparesis Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Ambulatory Surgical Center
Others
Global Gastroparesis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gastroparesis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastroparesis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Gastroparesis Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Abbott
Bausch Health
Boston Scientific
C.R. Bard
Johnson & Johnson
Cardinal Health
Evoke Pharma
Rhythm Pharmaceuticals